Core Viewpoint - Beijing Zhongguancun Science and Technology Development (Holding) Co., Ltd. announced the withdrawal of the drug registration application for Acetaminophen and Oxycodone Tablets by its subsidiary Beijing Huasu Pharmaceutical Co., Ltd. to further improve the application materials [1][2]. Group 1: Basic Information - The drug name is Acetaminophen and Oxycodone Tablets, with a registration number of CYHS2404364 and a notification number of 2025L00518 [1]. - The National Medical Products Administration (NMPA) issued a termination notice agreeing to withdraw the registration application based on the applicant's request [1]. Group 2: Reasons for Withdrawal and Future Plans - The decision to withdraw the application was made after careful consideration, with plans to resubmit the application after improving the relevant research [2]. Group 3: Impact on the Company - The project for Acetaminophen and Oxycodone Tablets has seen a total investment of 8.861 million yuan, with 5.5371 million yuan capitalized and 3.3239 million yuan expensed as of the announcement date [3]. - The withdrawal of the drug registration application will not impact the company's current financial status or operating performance [4].

Core Viewpoint - The company Beijing Huasu Pharmaceutical Co., Ltd. has decided to withdraw its drug registration application for Oxycodone and Acetaminophen tablets to further improve the submission materials [1] Group 1: Company Actions - Beijing Huasu received a "Drug Registration Application Termination Notice" from the National Medical Products Administration, agreeing to withdraw the application for Oxycodone and Acetaminophen tablets [1] - The company plans to resubmit the drug registration application after enhancing the relevant research [1] Group 2: Regulatory Context - The withdrawal of the application is not an indication of termination of the project, but rather a step to refine the application process [1]

近日，市科委、中关村管委会公示2025年"高品质科技园区建设（第二批）"拟支持项目。中关村（朝阳）工业AI产业园成功入选"高品质科技园区建设"项 目。 | 序号 | 项目名称 | | --- | --- | | 1 | 中关村(海淀)具身智能创 新产业园高品质科技园区建 | | | 设项目 | | 2 | 中关村(海淀)国际机器人 产业园高品质科技园区建设 | | | 项目 | | 3 | 中关村 AI。北纬社区高品质 科技园区建设项目 | | 4 | 中关村(朝阳)互联网 3.0·产 业园高品质科技园区建设项 | | | 目 | | 5 | 中关村(朝阳)工业AI产业 | | | 园高品质科技园区建设项目 | | 6 | 中关村(朝阳)未来显示产 业园高品质科技园区建设项 | | | 目 | 2025年9月，中关村（朝阳）工业AI产业园获评"中关村特色产业园"，此次入选2025年"高品质科技园区建设（第二批）"拟支持项目，既是对中关村（朝 阳）工业AI产业园深耕工业AI赛道、构建科创服务体系的肯定，更是推动园区高质量发展的强劲动力。未来，中关村（朝阳）工业AI产业园将以此为契 机，持续聚焦工业AI核心赛道， ...

Core Viewpoint - The completion of the main structure of the Agricultural Zhongguancun Comprehensive Research Center project in Pinggu District marks a significant step in enhancing agricultural research and innovation in the region [1] Group 1: Project Overview - The project is located in the National Agricultural Science and Technology Park in Yuko Town, Pinggu District, with a total construction area of 38,000 square meters, including 26,000 square meters above ground and 12,000 square meters underground [1] - Facilities within the project will include pilot testing areas, research laboratories, a roadshow hall, meeting rooms, and commercial support [1] Group 2: Collaboration and Focus Areas - The project will host the International Cooperation Science Center for Health, established in collaboration with China Agricultural University, focusing on "human-pet health synergy and integration of production, education, and research" [1] - The center aims to create an integrated platform for research, clinical applications, and industrial transformation, specifically targeting the pet economy, biological breeding, and synthetic biology [1] Group 3: Future Prospects - The project is expected to be officially operational by 2026 and aims to attract research talent and quality enterprises, thereby injecting strong momentum into the construction of the Agricultural Zhongguancun [1]

Core Viewpoint - The company Zhongguancun announced the withdrawal of its drug registration application for Acetaminophen and Oxycodone Tablets to further improve the submission materials, indicating that this is not the end of the project and that a resubmission will occur after necessary research is completed [2] Group 1 - The company Beijing Huasu, a subsidiary of Zhongguancun, received a notice from the National Medical Products Administration regarding the termination of the drug registration application for Acetaminophen and Oxycodone Tablets [2] - The total investment in the Acetaminophen and Oxycodone Tablets project amounts to 8.861 million yuan [2] - The withdrawal of the application will not impact the company's current financial status or operating performance [2]

关于下属公司北京华素氨酚羟考酮片药品注册申请进展的公告 共 2 页 证券代码：000931 证券简称：中关村 公告编号：2025-143 通知书编号：2025L00518 通知书主要内容：根据《药品注册管理办法》第八十九条以及申请人的撤 回申请，同意本品（氨酚羟考酮片）注册申请撤回，终止注册程序。 二、撤回原因及相关安排 北京中关村科技发展（控股）股份有限公司 关于下属公司北京华素氨酚羟考酮片药品注册申请进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）于 2024 年 12 月 19 日披露《关于下属公司北京华素氨酚羟考酮片收到国家药品监督管理 局<受理通知书>的公告》（公告编号：2024-106）。 近日，公司下属公司北京华素制药股份有限公司（以下简称：北京华素） 收到国家药品监督管理局（以下简称：国家药监局）签发的《药品注册申请终 止通知书》，同意撤回氨酚羟考酮片（规格：每片含盐酸羟考酮 5mg 和对乙酰 氨基酚 325mg）药品注册申请，现将相关情况公告如下： 一、基本信息 药品名称：氨 ...

Group 1 - The company Beijing Huasu Pharmaceutical Co., Ltd. has received a termination notice from the National Medical Products Administration regarding the drug registration application for Oxycodone and Acetaminophen Tablets [1] - The specific formulation of the drug includes 5mg of Oxycodone Hydrochloride and 325mg of Acetaminophen per tablet [1] - The termination notice indicates that the company has agreed to withdraw the drug registration application [1]

租赁资产为PVC防护手套生产线，账面凈值约为人民币1.02亿元。 公司的主要业务为向客户提供融资租赁及谘询服务。订立融资租赁协议为公司部分日常及一般业务，预 期将为公司带来稳定收入及现金流。董事认为订立融资租赁协议将在租赁期内为公司带来收入和利润， 符合公司业务发展策略。 中关村科技租赁(01601)发布公告，于2025年12月23日，公司作为出租人与承租人山东蓝帆新材料有限 公司订立融资租赁协议，据此，出租人将购入承租人自有租赁资产，转让价款为人民币1亿元;及出租人 将租赁资产租回给承租人，租赁期为24个月，总租赁款项约为人民币1.05亿元，包括融资租赁本金为人 民币1亿元及融资租赁利息收入(含增值税)约为人民币526万元。 ...

租赁资产为PVC防护手套生产线，账面凈值约为人民币1.02亿元。 智通财经APP讯，中关村科技租赁(01601)发布公告，于2025年12月23日，公司作为出租人与承租人山东 蓝帆新材料有限公司订立融资租赁协议，据此，出租人将购入承租人自有租赁资产，转让价款为人民币 1亿元;及出租人将租赁资产租回给承租人，租赁期为24个月，总租赁款项约为人民币1.05亿元，包括融 资租赁本金为人民币1亿元及融资租赁利息收入(含增值税)约为人民币526万元。 公司的主要业务为向客户提供融资租赁及谘询服务。订立融资租赁协议为公司部分日常及一般业务，预 期将为公司带来稳定收入及现金流。董事认为订立融资租赁协议将在租赁期内为公司带来收入和利润， 符合公司业务发展策略。 ...

格隆汇12月23日丨中关村科技租赁(01601.HK)公告，于2025年12月23日，公司作为出租人与承租人山东 蓝帆新材料订立融资租赁协议，据此，(i)出租人将购入承租人自有租赁资产，转让价款为人民币10,000 万元；及(ii)出租人将租赁资产租回给承租人，租赁期为24个月，总租赁款项约为人民币10,526万元，包 括融资租赁本金为人民币10,000万元及融资租赁利息收入(含增值税)约为人民币526万元。 ...